NCT06751875View on ClinicalTrials.gov

PRASED - Preventing Relapse After Successful Electroconvulsive Therapy for Depression

NAActive, not recruitingINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

July 26, 2019

Primary Completion Date

September 19, 2024

Study Completion Date

April 30, 2025

Conditions
Major Depressive Disorder (MDD)
Interventions
DRUG

Lithium

Patients are randomized to either receive lithium or not.

Trial Locations (1)

2610

Collaborative Antwerp Psychiatric Research Institute (CAPRI), Wilrijk

All Listed Sponsors
lead

Universiteit Antwerpen

OTHER

NCT06751875 - PRASED - Preventing Relapse After Successful Electroconvulsive Therapy for Depression | Biotech Hunter | Biotech Hunter